6Over U,Gur D, Unal S, et al. The changing nature of aminogiycoside resistance mechanisms and prevalence of newly recognized resistance mechanismsin Turkey[J]. Clin Microbiol Infect,2001,7(9) :470
7Patrieia A, Bradford. Extended -Speetumβ -Laetamase in the21st Century : characterization, epidemiology, and deletion of this important resistance theat[J].Clin Microbiol Rev ,2001,14 (4) :933 - 937
3[2]Oreste A M. Recent advances in chemistry and biochemistry of β -lactam asβ -lactamases inhibitor. Recent progress in the chemical synthesis of antibiotics and related microbial products[M].SprihgerVeriag, Berlin, 1993.
4[4]Bulychev A. Potent mechanism-based inhibition of the TEM-1β -lactamases by novel N-sulfonyloxyβ-lactams[J]. J Am Chem Soc. 1995,117:5983.
5[5]Perry C M,Markhan A.Piperacillin/Tazobactam. An updated review of use in the treatment of bacterial infections[J]. Druds. 1999.57(5):805-843.
6[6]Li X Z,Li Z, Ramakrishnan S ,et al. β -lactamases inhibitor are subatrates for the mulitidrug efflux pumps of Pseudomonas aeruginosa[J].Antimicrob Agents Chemther, 1998,42:399-403.
7[7]Payne D J, Bateson J H, Gasson B C, et al. Inhibition of Metallo-beta-lactamases by a series of Mercaptoacetic Acid Thiol Ester Derivatives[J]. Antimicrob Ag Chemother 1997, 41 (1): 135-140.
8[8]Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-beta-lactamase producing gram-negative bacteria by using thiol compounds [J]. Clin.Microbiol, 2000, 38(1):40～43.
9[9]Hommond G G, Huber J L, Greenlee M L, et al. Inhibition of IMP- 1 metallo-beta-lactamase and sensitization of IMP- 1-producing bacteria by thioester derivative[J].FEMS Microbiol Lett, 1999, 179(2):289-296.
10[11]Nagano R, Adachi Y, Imamura H, et al. Carbapenem derivatives as potential inhibitors of various betalactamases including class B metallo-beta-lactamases[J].Antimierob Ag Chemother, 1999, 43(I0): 2497-2503.
3Kirst HA. Antibiotics versus resistant bacteria: a continual challenge[J]. Expert Opin Ther Pat, 2010, 20(10): 1271-1272.
4Moller JK. Fighting drug-resistant hospital bacteria-less antibiotics and more infection control[J]. Ugeskr Laeger, 2011, 173(37): 2264-2266.
5Freire-Moran L, Aronsson B, Manz C, et al. ECDC-EMA Working Group.Critical shortage of new antibiotics in development against multidrug-resistant bacteria-time to react is now[J]. Drug Resist Updat, 2011, 14(2): 118-124.
6McCarthy M. Resistant bacteria spread through US communities. 70% of isolates are now resistant to all beta-lactam antibiotics[J]. Lancet, 2003, 362(9395): 1554-1555.
7王霞.新抗菌药物研发:企业联手合作或成必然[N].医药经济报,2012-06-27.
8Bradford PA.Extended spectrum fl-lactamases in the 21st century: characterization, epidemiology and the detection of this importantresistance threat[J]. Clin Microbiol Rev, 2001, 14(4): 933-951.
